CURRENT ISSUE Current Issue Cover
VOL 9 • NO 6 SEP/OCT 2018
IN THIS ISSUE

Cancer and Obesity: Am I Part of the Problem?

Pamela Hallquist Viale, RN, MS, CNS, ANP

Development of a Practice Standard for Monitoring Adult Patients Receiving Bone-Modifying Agents at a Community Cancer Center

Anton Nguyen,(1) PharmD, Joseph A. Kalis,(2) PharmD, BCOP, Theresa R. Sutz,(1) PharmD, and Kate D. Jeffers,(2) PharmD, BCOP

Systemic Treatments for Lung Cancer Patients Receiving Hemodialysis

Tzewah V. Leung, PharmD, BCOP, Mitchell E. Hughes, PharmD, BCPS, BCOP, Christine G. Cambareri, PharmD, BCPS, BCOP, Daniel J. Rubin, PharmD, and Beth Eaby-Sandy, MSN, CRNP, OCN®

Diagnostic Snapshot: Acute Edema in the Oncology Patient

Alexandra Trudeau, BSN, BS, RN, CNOR, Danielle Bean, BSN, RN, Donna Fleming, MSN, RN, FNP-C, Glaiza Boado, BSN, RN, Natalia Samuels, MSN, RN, and Reshmi Kurup, BS, RN

 
Section Seperator

TODAY'S NEWS

ESMO 2018: About 1 in 6 Premenopausal Pa...

Nearly 1 in 6 premenopausal women being treated fo...

ESMO 2018: Short-HER Trial Examines Abbr...

Women with HER2-positive early breast cancer with ...

ESMO 2018: Pooled Analysis of Influence ...

In an analysis presented by Davidson et al, data w...

ESMO 2018: Variations Between European C...

Some European countries take more than twice as lo...

Adoptive T-Cell Therapy for Progressive ...

An emerging treatment known as adoptive T-cell the...

More News From Today More News
Section Seperator

EDITORIALS & COMMENTARY

Caring for Adult Children With Cancer

Cancer affects over 60,000 young adults aged 20 to 39 each year...

Comprehensive Geriatric Assessment in Oncology

Cancer is a disease of aging. According to the Centers for Disease Control and Prevention...

Allogeneic Stem Cell Transplant Patients

Every year in the U.S., thousands of adults are diagnosed with life-threatening hematologic malignancies such as leukemia and lymphoma...

Initial Febrile Neutropenia Management

Febrile neutropenia is an oncologic emergency requiring immediate evaluation and treatment...

Inotuzumab Ozogamicin in B-Cell ALL

ALL accounts for approximately 20% of all adult leukemias...

More Editorials & Commentary More Tweets
 
Section Seperator

PREVIOUS HIGHLIGHTS

Regular Aspirin Use and Reduction in Ris...

A pooled analysis of two large U.S. prospective co...

Adjuvant Chemotherapy in High-Grade Uter...

As reported in the Journal of Clinical Oncology by...

Genomic Classification of Myeloprolifera...

In a study reported in The New England Journal of ...

Established, Modifiable Cancer Risk Fact...

According to a new American Cancer Society report ...

Chemotherapy-Free Initial Treatment of A...

In an analysis of two Nordic Lymphoma Group trials...

More Highlights More Highlights
 
Section Seperator
Section Seperator
 
 
Section Seperator
ADVERTISEMENT
Section Seperator
ADVERTISEMENT
Section Seperator
ADVERTISEMENT
Section Seperator
Copyright © 2010-2018 Harborside Press, LLC All rights reserved.               
Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact | Copyright Notice/Disclaimer | Subscribe
Bot trap - Don't go here
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.